45th ISOBM (International Society of Oncology & BioMarkers) 2018 CONGRESS
Tumor diagnosis and therapy - role of Biomarkers
The 2018 Congress has the aim to bring together participants active in all fields of basic and clinical research in Oncology, in order to optimize clinical results in cancer prevention, diagnosis and therapy.
More than before, Biomarkers hold out promise for improving the outcome of cancer patients by optimization of diagnostic procedures in combination with clinical parameters and various imaging methods. By continuous development of standardization, quality contol and automatization, as well as by applying new individualized targeted treatments, we succeed now to improve patients state and survival.The new therapeutic agents can be combined with the established chemo-radiotherapy of Cancer disease.